MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 20:04:45 07/06/2024 BST | ||
| 11.14 EUR | +6.91% |
|
| Current month | -7.46% | ||
| 1 month | -10.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 11.14 | +6.91% |
| 06/06/24 | 10.42 | +3.68% |
| 05/06/24 | 10.05 | -2.99% |
| 04/06/24 | 10.36 | -2.72% |
| 03/06/24 | 10.65 | -5.42% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 08:04 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ5S1H |
| ISIN | DE000DJ5S1H7 |
| Date issued | 26/10/2023 |
| Strike | 344.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.62 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.64 € |
|---|---|
| Lowest since issue | 7.02 € |
| Spread | 0.02 € |
| Spread % | 0.18% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
232
USD
Average target price
284.6
USD
Spread / Average Target
+22.70%
- Stock Market
- Certificates
- Certificat